It has been shown that CD4 T cells are crucial to the immunopathogenesis of vaccine-augmented RSV disease [4,66,67], and that RSV-specific antibodies (in the absence of CD4 and CD8 T cells) are not sufficient to cause disease enhancement [4,66]. This evidence concerns the gene CD8A and glycogen storage disease VI.